![](https://d3ilqtpdwi981i.cloudfront.net/sIdprzyULVh3FQWUMGwf0POFiU8=/0x0:115x150/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/f6/e9/b9/f6e9b96f-b569-4bb6-856b-05266c203710/jco.2010.31.28.issue-28.cover.gif)
Article
A Phase Ib/II Trial of Trastuzumab-DM1 (T-DM1) with Pertuzumab (P) for Women with HER2-positive, Locally Advanced or Metastatic Breast Cancer (BC) who were Previously Treated with Trastuzumab (T).
Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting
(2010)
Disciplines
Publication Date
2010
Citation Information
Reshma Mahtani, K. Miller, L. Gianni, F. Andre, et al.. "A Phase Ib/II Trial of Trastuzumab-DM1 (T-DM1) with Pertuzumab (P) for Women with HER2-positive, Locally Advanced or Metastatic Breast Cancer (BC) who were Previously Treated with Trastuzumab (T)." Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting Vol. 28 Iss. 15S (2010) Available at: http://works.bepress.com/reshma-mahtani/9/